Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"28,705 (16,080, 48,530)","50.2% (35.1%, 63.0%)","72.5% (48.6%, 88.3%)","18.1% (8.6%, 35.6%)","47.9% (33.0%, 60.8%)","17.6 (12.3, 22.0)","25.4 (17.0, 30.9)","6.3 (3.0, 12.4)","16.8 (11.6, 21.3)",,,,,
"p=(None, None), q=(None, None), c=0.500, f=1.00)","24,790 (12,397, 45,008)","59.2% (39.5%, 75.0%)","40.3% (25.5%, 55.8%)","9.0% (5.2%, 14.4%)","56.6% (37.5%, 72.3%)","20.7 (13.8, 26.2)","14.1 (8.9, 19.5)","3.2 (1.8, 5.0)","19.8 (13.1, 25.3)","-14.6% (-31.1%, -2.4%)","17.8% (5.5%, 34.2%)","-44.3% (-62.1%, -23.0%)","-45.7% (-74.6%, 0.9%)","18.0% (5.6%, 34.4%)"
"p=(None, None), q=(None, None), c=0.750, f=1.00)","24,889 (12,337, 45,009)","59.4% (39.5%, 76.4%)","39.6% (24.6%, 54.7%)","8.7% (5.0%, 13.9%)","57.0% (37.7%, 73.8%)","20.8 (13.8, 26.7)","13.9 (8.6, 19.2)","3.1 (1.8, 4.9)","19.9 (13.2, 25.8)","-14.2% (-30.9%, -2.2%)","18.2% (5.2%, 34.8%)","-45.3% (-63.4%, -25.3%)","-47.7% (-75.5%, -7.9%)","18.9% (5.4%, 36.4%)"
"p=(None, None), q=(None, None), c=1.000, f=1.00)","24,966 (12,349, 44,917)","59.7% (39.5%, 75.8%)","39.2% (24.7%, 55.5%)","8.4% (4.9%, 13.5%)","57.3% (37.6%, 73.0%)","20.9 (13.8, 26.5)","13.7 (8.6, 19.4)","3.0 (1.7, 4.7)","20.1 (13.1, 25.5)","-13.8% (-32.3%, -2.6%)","18.8% (6.9%, 34.2%)","-45.9% (-63.7%, -25.2%)","-49.3% (-76.0%, -9.1%)","19.6% (7.2%, 35.5%)"
